Longboard Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, with an initial focus on rare diseases.

Stock Quote

Price

Change

High

View DetailsStock Lookup

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Corporate Presentation

Latest News

September 21, 2021
Longboard Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference on September 28, 2021 »

September 8, 2021
Longboard Pharmaceuticals Successfully Completes LP352 Multiple Ascending Dose Portion of Phase 1 Clinical Trial in Healthy Volunteers, Plans to Initiate Phase 1b/2a Clinical Trial »

August 31, 2021
Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences »

Learn More »

Latest Events

Sep 28, 2021 11:20 AM EDT
Cantor Global Healthcare Conference »

Sep 13, 2021 7:00 AM EDT
H.C. Wainwright’s Global Investment Conference »

Sep 8, 2021 3:15 PM EDT
Citi’s BioPharma Conference »

Learn More »